All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...703Next →

hiv & aids news selected from other sources

  • PrEP
    So Why Are So Many Gay Men Opposed To PrEP?
    TheGayUK | 15 hours ago

    "About nine months ago, the GUM clinic I regularly attend (the Working Men’s Project at St Mary’s in Paddington) offered me the chance to be part of the PROUD study, which examines the impact on gay men of using Pre-Exposure Prophylaxis (PrEP), and I jumped at the chance, not only because I wanted to do my bit for the community, but because it offered me an extra level of protection against HIV, regardless of whether I was using condoms or not."

  • Hepatitis C treatment
    The Risky Business of Limiting Medicaid Access to Sovaldi
    Governing | 21 hours ago

    Partially because of its high cost, nearly half the states are restricting Medicaid patients' access to an effective new hepatitis C drug. Experts say there’s no question lawsuits will come.

  • New report finds missing and incomplete data imperils the global HIV/AIDS response
    AVAC | 22 hours ago

    A new report from amfAR, The Foundation for AIDS Research, and AVAC outlines the need for a new approach to tracking data to guide the key decisions that shape the response to the HIV/AIDS epidemic. Critical and expensive decisions made with incomplete data are undermining the response—even as the systems for collecting this data continue to improve, the report found.

  • Hepatitis C treatment
    Nearly Half of Surveyed US Specialists Expect to Prescribe Gilead's Sofosbuvir / Ledipasvir Regimen Near-Term for Hepatitis C Infections
    Decision Resources Group press release | 22 hours ago

    Analysis of surveyed specialists' near-term prescribing intent indicates that nearly one in every four actively treated genotype 1 patients will be prescribed the sofosbuvir/ledipasvir regimen in the next six months. However, the on-treatment patient shares for the off-label Olysio (Janssen) and Sovaldi combination regimen are expected to remain stable over this period.

  • The search for a cure
    2000-Fold Drop in Latent Reservoir Needed for 1 Year Without ART
    International AIDS Society | 22 hours ago

    About a 2000-fold reduction in the HIV reservoir in resting CD4 cells may be needed to let most people stop antiretroviral therapy (ART) for a single year without rebound, according to results of a modeling study. Predicted large variations in rebound times after ART stops mean close monitoring will be required for this strategy.

  • Finance and funding
    Global Fund Investment Guidance for Eastern Europe and Central Asia
    Global Fund to Fight AIDS, TB and Malaria | 22 hours ago

    The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.

  • Epidemiology
    Kenya: Young women lead in new HIV infections - study
    The Standard Digital News | 22 hours ago

    Women aged between 15 and 24 years account for 21 per cent of new HIV infections in the country, a new report says. The report says approximately 88,620 new HIV infections occurred among adults and 12,940 among children last year.

  • Prevention of mother-to-child transmission
    Zambia: PMTCT Real Life Story
    Times of Zambia | 22 hours ago

    The pain of living through the loss of three children was enough to discourage Constance Mudenda from ever contemplating parenting. When she was pregnant, her greatest desire was to have a child born free of HIV, and now she will continue to mentor her daughter to ensure she is protected from acquiring HIV.

  • How HIV causes disease
    How HIV co-opts gut bacteria to pose as a familiar infection
    The Conversation UK | 22 hours ago

    One of the most effective methods used by HIV to evade control is to hide from the immune system. B-cells are crucial for controlling new infections, producing specific antibodies to attack it, which coat the surface of infected cells and tag them for destruction. But according to a study from Duke Medicine, published in Cell Host & Microbe, when HIV enters and begins replicating in the gut, the reaction of B cells is ineffective because the virus is able to pose as a “good” bacterium. Its gp41 surface protein - which is displayed on the surface of infected cells - looks like surface proteins on the cells of friendly gut bacteria.

  • Sexual transmission
    Getting to the bottom of it: Anal sex, rectal fluid, and HIV transmission
    CATIE | 20 August 2014

    While there is no doubt that semen, pre-ejaculate (pre-cum), and blood can contribute to the risk of HIV transmission through anal sex; it seems there is less clarity among frontline service providers on whether rectal fluid should also be included on this list. This article looks at what rectal fluid is, whether or not it can contain and transmit HIV, and the implications for prevention education.

← First12345...928Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.